TABLE 4.
Factors influencing treatment in the PRE and POST study phases
| Factor | PRE (n = 30) |
POST (n = 21) |
||
|---|---|---|---|---|
| Treated with azithromycin (n = 6) | Not treated with azithromycin (n = 24) | Treated with azithromycin (n = 15) | Not treated with azithromycin (n = 6) | |
| Time—onset of symptom to ED visit, median (range) days | 1.5 (0–2) | 1 (0–6) | 2 (0–6) | 2 (1–4) |
| No. of diarrheal episodes, median (range) | 7 (5–13) | 5.5 (1–20) | 5.5 (1–27) | 3.5 (1–13) |
| Bloody diarrhea, no. | 3 | 3 | 7 | 1 |
| Oral rehydration, no. | 1 | 10 | 7 | 6 |
| Coinfections, no.a | 5, Shigella; 1, multiple pathogens | 10, Shigella; 14, multiple pathogens | 12, Shigella; 3, multiple pathogens | 3, Shigella; 3, multiple pathogens |
a
Among the coinfections, EPEC was the most common pathogen as detected by the GI panel.